Vycor Medical (VYCO) Cash & Current Investments (2010 - 2026)
Vycor Medical's (VYCO) quarterly Cash & Current Investments came in at $158907.0 in Q2 2026, up 59.39% year-over-year from $99700.0 in Q2 2025, and down 8.48% quarter-over-quarter from $173634.0 in Q1 2026.
Powered by 
Analysis
Vycor Medical (VYCO) Cash & Current Investments (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has reported Cash & Current Investments for 17 consecutive years, with $158907.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash & Current Investments rose 59.39% year-over-year to $158907.0 in Q2 2026; TTM through Jun 2026 was $158907.0, a 59.39% increase from a year earlier, with the FY2025 full-year figure at $86982.0, down 17.67% from the prior year.
- Cash & Current Investments was $158907.0 for Q2 2026 at Vycor Medical, down from $173634.0 in the prior quarter.
- Over five years, Cash & Current Investments peaked at $173634.0 in Q1 2026 and troughed at $32570.0 in Q3 2022.
- A 5-year average of $82904.6 and a median of $66642.5 in 2023 frame the typical range for Cash & Current Investments.
- Across the five-year window, Cash & Current Investments sank 59.87% in 2022 and surged 184.42% in 2026, its largest moves.
- Over 5 years, Cash & Current Investments stood at $37035.0 in 2022, then jumped by 54.69% to $57291.0 in 2023, then jumped by 84.41% to $105648.0 in 2024, then declined by 17.67% to $86982.0 in 2025, then surged by 82.69% to $158907.0 in 2026.
- The last three Cash & Current Investments figures came in at $158907.0 (Q2 2026), $173634.0 (Q1 2026), and $86982.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 5.22 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 8.82 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 3.48 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 539.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 4.25 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 1.46 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 1.95 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Vycor Medical | 2.34 Mn | 2.18 Mn | 344,445.00 | 158,907.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 158,907.00 |
| Mar 31, 2026 | 173,634.00 |
| Dec 31, 2025 | 86,982.00 |
| Sep 30, 2025 | 64,230.00 |
| Jun 30, 2025 | 99,700.00 |
| Mar 31, 2025 | 61,049.00 |
| Dec 31, 2024 | 105,648.00 |
| Sep 30, 2024 | 157,633.00 |
| Jun 30, 2024 | 119,296.00 |
| Mar 31, 2024 | 43,857.00 |
| Dec 31, 2023 | 57,291.00 |
| Sep 30, 2023 | 69,055.00 |
| Jun 30, 2023 | 53,404.00 |
| Mar 31, 2023 | 47,805.00 |
| Dec 31, 2022 | 37,035.00 |
| Sep 30, 2022 | 32,570.00 |
| Jun 30, 2022 | 43,619.00 |
| Mar 31, 2022 | 80,567.00 |
| Dec 31, 2021 | 90,941.00 |
| Sep 30, 2021 | 78,573.00 |